Celebrating 25 years Est 1999-2024
*Across 3 years $2158.56 only $1079.28
4SC (Frankfurt, Prime Standard: VSC), a drug discovery and development company focused on autoimmune and cancer indications...
4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company focused on autoimmune and cancer indications...
4SC AG (Frankfurt, Prime Standard: VSC) a drug discovery and development company focused on autoimmune and cancer indications...
4SC AG (Frankfurt, Prime Standard: VSC) a drug discovery and development company, will announce its financial results 2009 (ended...
4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company, today announced the start of dosing in a...
4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company, today announced that the European Patent...
Ad hoc announcement in accordance with §15 WpHG [Securities Trading Act] 4SC AG (Frankfurt, Prime Standard: VSC), a drug...
4SC AG (Frankfurt, Prime Standard: VSC) the German drug discovery and development company, today announced the dosing of the...
The drug discovery and development company 4SC AG (Frankfurt, Prime Standard: VSC) today announced that it will present new...
4SC AG (Frankfurt, Prime Standard: VSC) the German drug discovery and development company, in conjunction with Royal Marsden...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.